Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Beam Therapeutics Inc. | 33,662 | reported | 04 Jun 2025 | tx 2+72,748 |
| Merck & Co., Inc. | 19,402 | reported | 05 May 2026 | tx 21+382,107−204,281 |
| BIOGEN INC. | 12,519 | reported | 18 Feb 2022 | tx 49+67,743−36,048 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 May 2026 | GRANT_AWARD | Merck & Co., Inc. | 6,628 | 0.00 USD | deriv |
| 05 May 2026 | GRANT_AWARD | Merck & Co., Inc. | 19,402 | 0.00 USD | deriv |
| 12 Feb 2026 | SALE | Merck & Co., Inc. | 10,000 | 121.46 USD | |
| 09 Feb 2026 | SALE | Merck & Co., Inc. | 10,000 | 118.41 USD | |
| 05 Feb 2026 | SALE | Merck & Co., Inc. | 20,000 | 121.88 USD | |
| 26 Jan 2026 | GRANT_AWARD | Merck & Co., Inc. | 9,865 | 107.40 USD | |
| 04 Aug 2025 | EXERCISE | Merck & Co., Inc. | 36,903 | 79.29 USD | |
| 04 Aug 2025 | TAX_WITHHOLDING | Merck & Co., Inc. | 18,175 | 79.29 USD | |
| 04 Aug 2025 | EXERCISE | Merck & Co., Inc. | 36,903 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Beam Therapeutics Inc. | 33,662 | 0.00 USD | deriv |
| 29 Apr 2025 | GRANT_AWARD | Merck & Co., Inc. | 5,902 | 0.00 USD | deriv |
| 29 Apr 2025 | GRANT_AWARD | Merck & Co., Inc. | 26,867 | 0.00 USD | deriv |
| 27 Jan 2025 | GRANT_AWARD | Merck & Co., Inc. | 28,158 | 97.94 USD | |
| 02 Dec 2024 | GRANT_AWARD | Beam Therapeutics Inc. | 39,086 | 0.00 USD | deriv |
| 05 Aug 2024 | EXERCISE | Merck & Co., Inc. | 36,901 | 115.20 USD | |
| 05 Aug 2024 | TAX_WITHHOLDING | Merck & Co., Inc. | 17,412 | 115.20 USD | |
| 05 Aug 2024 | EXERCISE | Merck & Co., Inc. | 36,901 | 0.00 USD | deriv |
| 30 Apr 2024 | GRANT_AWARD | Merck & Co., Inc. | 29,297 | 0.00 USD | deriv |
| 03 Aug 2023 | EXERCISE | Merck & Co., Inc. | 36,901 | 105.70 USD | |
| 03 Aug 2023 | TAX_WITHHOLDING | Merck & Co., Inc. | 17,989 | 105.70 USD | |
| 03 Aug 2023 | EXERCISE | Merck & Co., Inc. | 36,901 | 0.00 USD | deriv |
| 02 May 2023 | GRANT_AWARD | Merck & Co., Inc. | 34,578 | 0.00 USD | deriv |
| 03 Aug 2022 | GRANT_AWARD | Merck & Co., Inc. | 110,705 | 0.00 USD | deriv |
| 18 Feb 2022 | EXERCISE | BIOGEN INC. | 1,981 | 0.00 USD | |
| 18 Feb 2022 | TAX_WITHHOLDING | BIOGEN INC. | 879 | 209.79 USD |